Movement Disorders

Papers
(The H4-Index of Movement Disorders is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Information431
139
John Michael Walshe (April 24, 1920–October 14, 2022)113
Severe Dyskinesia After Administration of SARS‐CoV2 mRNA Vaccine in Parkinson's Disease111
In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease104
Has Parkinson Disease Gone to the Dogs?104
FARS‐ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change91
Clinical and Molecular Spectrum of Autosomal Recessive CA8‐Related Cerebellar Ataxia87
The Pathogenesis of Paroxysmal Kinesigenic Dyskinesia: Current Concepts85
85
Complex Ataxia‐Dementia Phenotype in Patients with Digenic TBP/STUB1 Spinocerebellar Ataxia82
82
Issue Information80
DBSMatchMaker: Connecting Clinicians Globally for Deep Brain Stimulation in Rare Diseases77
Movement Disorders: Volume 39, Number 4, April 202475
73
Blocking the Self‐Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition68
Negative Myoclonus: Neurophysiological Study and Clinical Impact in Progressive Myoclonus Ataxia67
An Exploratory, Randomized, Double‐Blind Clinical Trial of Dipraglurant for Blepharospasm67
Reply to: “Is Gait Dysfunction Prominent Sign of Isolated Rapid Eye Movement Sleep Behavior Disorder?”67
Unraveling the Twist: Spatial Navigational Challenges in Cervical Dystonia66
Covid‐19 Infection and Parkinsonism: Is There a Link?65
Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration62
Response to Mortimer et al. “Clinical and molecular profiling in GNAO1 permits phenotype–genotype correlation”61
Confirmation of a Causal Role for SHQ1 Variants in Early Infantile‐Onset Recessive Dystonia61
Responsive Deep Brain Stimulation: A New Hope for Controlling Stimulation‐Induced Dysarthria in Essential Tremor59
Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease58
57
Canine RNF170 Single Base Deletion in a Naturally Occurring Model for Human Neuroaxonal Dystrophy57
Epidemiology of Huntington's Disease in Latin America: A Systematic Review and Meta‐Analysis56
Long‐Read Sequencing Unravels the Complexity of Structural Variants in PRKN in Two Individuals with Early‐Onset Parkinson's Disease56
Prokineticin‐2 Is Highly Expressed in Colonic Mucosa of Early Parkinson's Disease Patients56
Severe Acute Motor Exacerbations (SAME) across Metabolic, Developmental and Genetic Disorders56
September Infographic55
Functional Movement Disorder as a Prodromal Symptom of Parkinson's Disease—Clinical and Pathophysiological Insights55
Reply to: “CAG Repeat Expansion in THAP11 is Not Detected in a Cohort with Spinocerebellar Ataxia from Hokkaido, the Northernmost Island of Japan”54
A New Case Series Suggests That SCA48 (ATX/STUB1) Is Primarily a Monogenic Disorder54
Clinical and Molecular Profiling in GNAO1 Permits Phenotype–Genotype Correlation53
November Infographic53
Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population‐Based Cohort Study53
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure52
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait52
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers51
Gait Variability in Spinocerebellar Ataxia Assessed Using Wearable Inertial Sensors50
ANO3 as a Cause of Early‐Onset Chorea Combined with Dystonia: Illustration of Phenotypic Evolution48
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension48
Longitudinal Associations of Magnetic Susceptibility with Clinical Severity in Parkinson's Disease47
0.18602609634399